Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trial
Lee, Chee Khoon × Lord, Sarah Grunewald, Tami Gebski, Val Hardy-Bessard, Anne-Claire Sehouli, Jalid Woie, Kathrine Heywood, Mark Schauer, Christian Vergote, Ignace Scambia, Giovanni Ferrero, Annamaria Harter, Philipp Pujade-Lauraine, Eric Friedlander, Michael #
Gynecologic Oncology vol:136 issue:1 pages:18-24
The role of secondary cytoreductive surgery (SCR) in platinum-sensitive recurrent ovarian cancer (ROC) remains controversial. The overall survival (OS) benefits for surgery reported in observational studies may be due to the selection of patients with better prognosis.